Resiliency in Total Joint Arthroplasty
1 other identifier
interventional
18
1 country
1
Brief Summary
The investigators primary objective is to determine how does participation in StreaMD affect patient reported outcomes after Total Hip Arthroplasty (THA) or Total Knee Arthroplasty (TKA)?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 5, 2020
CompletedFirst Submitted
Initial submission to the registry
April 15, 2020
CompletedFirst Posted
Study publicly available on registry
April 22, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 12, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 12, 2022
CompletedJuly 15, 2022
July 1, 2022
1.9 years
April 15, 2020
July 13, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Patient Reported Outcome Score (PROMIS) following THA or TKA
Patient reported outcome will consist of the Patient-Reported Outcomes Measurement Information System (PROMIS)
Follow Up Visits up to 2-Years
Patient Reported Outcome Score (HOOS Jr.) following THA or TKA
Patient reported outcome will consist of the hip disability and osteoarthritis outcome score (HOOS Jr.)
Follow Up Visits up to 2-Years
Patient Reported Outcome Score (KOOS Jr.) following THA or TKA
Patient reported outcome will consist of the knee injury and osteoarthritis outcome score (KOOS Jr.)
Follow Up Visits up to 2-Years
Study Arms (2)
Control
NO INTERVENTIONNo other non-standard of care activities will be performed
Intervention
EXPERIMENTALWill be signed up for the automated text messaging program (StreaMD)
Interventions
Patients who are randomized to the intervention arm will be signed up for the automated text messaging program. Patients will receive automated text messages related to their surgery during the study period and can also ask questions through the text messages program, where automated messages will be sent based on the questions asked.
Eligibility Criteria
You may qualify if:
- All patients aged 18 and older who are receiving a total hip or knee replacement.
You may not qualify if:
- Patients enrolled in the MyMobility study
- Patients who do not have cell phones with text messaging capability
- Non-English speaking patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Utah Orthopaedic Center
Salt Lake City, Utah, 84108, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeremy Gililland, M.D.
University of Utah
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
April 15, 2020
First Posted
April 22, 2020
Study Start
March 5, 2020
Primary Completion
January 12, 2022
Study Completion
January 12, 2022
Last Updated
July 15, 2022
Record last verified: 2022-07